Drug Profile
Haem arginate - Orphan Europe
Alternative Names: Hemin - Orphan Europe; NormosangLatest Information Update: 02 Oct 2021
Price :
$50
*
At a glance
- Originator Orphan Europe
- Developer CMIC; Orphan Europe
- Class Antibacterials; Antineoplastics; Haemes
- Mechanism of Action Enzyme replacements
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- Marketed Acute intermittent porphyria